Merck reported better-than-expected quarterly results, with sales of newer drugs mostly offsetting declining sales of drugs facing generic competition.» Read More
Citigroup now needs a steady hand to bring the bank to its full potential, Dick Bove says.
The weather phenomenon is likely to return, possibly bringing enough water to end the severe drought in California.
When it comes to investing, those at opposite ends of the economic spectrum are going in totally different directions.
Hedge fund manager Bill Ackman promised to pay a disgruntled ex-Herbalife executive as much as $3.60 million over the next 10 years, a report said.
Forget the harsh winter. Higher home prices are stifling sales around the country, and low inventories aren't helping.
Ford Motors is expected to name Mark Fields as successor to CEO Alan Mulally, sources told CNBC.
Hedge fund Starboard Value on Tuesday won consent from 54 percent of Darden shareholders to call a special meeting, sources told CNBC.
Travelers spent $27 billion in Vegas last year; and as millennials continue to drop more money on clubbing than on gambling, businesses are capitalizing on it.
A case involving start-up Aereo and broadcast TV networks is before the Supreme Court. The outcome could impact how consumers watch programming.
Male doctors on average make 88 percent more in Medicare reimbursements than female physicians, according to an analysis of government data.
Not only are middle class Americans losing out in the U.S., they are now trailing their global peers, the NYT reports.
Motorists who purchase battery-electric vehicles tend to be younger and more affluent than drivers of hybrid vehicles, according to a new study.
One of Valeant's top shareholders on Tuesday threw his support behind its proposed takeover bid for Botox-maker Allergan.
McDonald's reported a lower quarterly profit as sales at the fast-food chain's established U.S. restaurants fell more than expected.
With GE leading the way, the Internet of Things has experts giddy about what it could do not only for the global economy but for industrial stocks.
The megabillion-dollar deals with Novartis also allow GlaxoSmithKline to "significantly expand" its world-leading vaccine business, GSK's CEO tells CNBC.
With the Fed paring back its bond-buying program, retirees are bracing for volatility in bonds, but financial advisors are not overly concerned.
Valeant Pharmaceuticals and Bill Ackman are proposing a cash-and-stock deal for Allergan that could be worth about $45 billion.
If their co-signer dies or files for bankruptcy, students who take out private loans to pay for college might face an unexpected financial challenge.
Vice President Joe Biden told Ukrainian presidential candidates and Parliament that the U.S. was ready to help Ukraine and they must fight corruption.
Get the best of CNBC in your inbox
Dennis Gartman of "The Gartman Letter" says the action in El Pollo Loco could be indicative of a market top.
After news of the monster dollar-store merger, here's the thing no one seems to be talking about, says retail analyst Brian Sozzi.
As the market rises, now is the time to guard your portfolio against the volatility that can strike at any time.
Tom Naratil, UBS CFO, discusses UBS's settlement with Germany on tax evasion charges.
Tom Naratil, UBS CFO, discusses robust growth in UBS's wealth management division.
Jeffrey Rosenberg, BlackRock, shares his thoughts on Fed policy ahead of the FOMC meeting. We no longer need negative two percent interest rates and a massive size balance sheet, says Rosenberg.